Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alvaro Cerda

Showing results (41-50 of 55) with videos related to

Pageof 6
Sort By:
Frontiers in Pharmacology|November 30, 2018
Polymorphisms in mTOR and Calcineurin Signaling Pathways Are Associated With Long-Term Clinical Outcomes in Kidney Transplant RecipientsAntony Brayan Campos-Salazar, Fabiana Dalla Vecchia Genvigir, Claudia Rosso Felipe, et al.
Pharmacogenomics|September 24, 2010
Effects of lipid-lowering drugs on reverse cholesterol transport gene expressions in peripheral blood mononuclear and HepG2 cellsFabiana Dalla Vecchia Genvigir, Alice Cristina Rodrigues, Alvaro Cerda, et al.
Pharmacogenomics|December 19, 2019
<i>CYP3A5*3</i> and <i>CYP2C8*3</i> variants influence exposure and clinical outcomes of tacrolimus-based therapyFabiana Dalla Vecchia Genvigir, Antony Brayan Campos-Salazar, Claudia Rosso Felipe, et al.
Nutrition Research (New York, N.Y.)|January 18, 2025
Variants in GHRL, RETN, and PLIN1 are associated with obesity, diabetes, and metabolic syndrome, and influence food consumption in adults with obesityMarina Aparecida Dos Santos, Raul Hernandes Bortolin, Alvaro Cerda, et al.
Chemistry and Physics of Lipids|October 12, 2023
Lipidomic analysis identified potential predictive biomarkers of statin response in subjects with Familial hypercholesterolemiaAlvaro Cerda, Raul Hernandes Bortolin, Marcos Yukio Yoshinaga, et al.
Epigenomics|December 4, 2020
Differentially expressed urinary exo-miRs and clinical outcomes in kidney recipients on short-term tacrolimus therapy: a pilot studyRenata Caroline Costa Freitas, Raul Hernandes Bortolin, Fabiana Dalla Vecchia Genvigir, et al.
Pharmacogenetics and Genomics|July 20, 2016
Influence of the CYP3A4/5 genetic score and ABCB1 polymorphisms on tacrolimus exposure and renal function in Brazilian kidney transplant patientsFabiana D V Genvigir, Patricia C Salgado, Claudia R Felipe, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|March 19, 2013
Effects of atorvastatin on CYP3A4 and CYP3A5 mRNA expression in mononuclear cells and CYP3A activity in hypercholeresterolemic patientsMaria Alice V Willrich, Alice C Rodrigues, Alvaro Cerda, et al.
International Journal of Molecular Sciences|February 5, 2021
Peripheral Blood miRome Identified miR-155 as Potential Biomarker of MetS and Cardiometabolic Risk in Obese PatientsAlvaro Cerda, Adonai Aralim Amaral, Raquel de Oliveira, et al.
Pharmaceutics|May 28, 2022
Genetic Variant <i>ABCC1</i> rs45511401 Is Associated with Increased Response to Statins in Patients with Familial HypercholesterolemiaCarolina Dagli-Hernandez, Jéssica Bassani Borges, Elisangela da Silva Rodrigues Marçal, et al.
Pageof 6

Showing results (41-50 of 55) with videos related to

Sort By:
Pageof 6
Frontiers in Pharmacology|November 30, 2018
Polymorphisms in mTOR and Calcineurin Signaling Pathways Are Associated With Long-Term Clinical Outcomes in Kidney Transplant RecipientsAntony Brayan Campos-Salazar, Fabiana Dalla Vecchia Genvigir, Claudia Rosso Felipe, et al.
Pharmacogenomics|September 24, 2010
Effects of lipid-lowering drugs on reverse cholesterol transport gene expressions in peripheral blood mononuclear and HepG2 cellsFabiana Dalla Vecchia Genvigir, Alice Cristina Rodrigues, Alvaro Cerda, et al.
Pharmacogenomics|December 19, 2019
<i>CYP3A5*3</i> and <i>CYP2C8*3</i> variants influence exposure and clinical outcomes of tacrolimus-based therapyFabiana Dalla Vecchia Genvigir, Antony Brayan Campos-Salazar, Claudia Rosso Felipe, et al.
Nutrition Research (New York, N.Y.)|January 18, 2025
Variants in GHRL, RETN, and PLIN1 are associated with obesity, diabetes, and metabolic syndrome, and influence food consumption in adults with obesityMarina Aparecida Dos Santos, Raul Hernandes Bortolin, Alvaro Cerda, et al.
Chemistry and Physics of Lipids|October 12, 2023
Lipidomic analysis identified potential predictive biomarkers of statin response in subjects with Familial hypercholesterolemiaAlvaro Cerda, Raul Hernandes Bortolin, Marcos Yukio Yoshinaga, et al.
Epigenomics|December 4, 2020
Differentially expressed urinary exo-miRs and clinical outcomes in kidney recipients on short-term tacrolimus therapy: a pilot studyRenata Caroline Costa Freitas, Raul Hernandes Bortolin, Fabiana Dalla Vecchia Genvigir, et al.
Pharmacogenetics and Genomics|July 20, 2016
Influence of the CYP3A4/5 genetic score and ABCB1 polymorphisms on tacrolimus exposure and renal function in Brazilian kidney transplant patientsFabiana D V Genvigir, Patricia C Salgado, Claudia R Felipe, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|March 19, 2013
Effects of atorvastatin on CYP3A4 and CYP3A5 mRNA expression in mononuclear cells and CYP3A activity in hypercholeresterolemic patientsMaria Alice V Willrich, Alice C Rodrigues, Alvaro Cerda, et al.
International Journal of Molecular Sciences|February 5, 2021
Peripheral Blood miRome Identified miR-155 as Potential Biomarker of MetS and Cardiometabolic Risk in Obese PatientsAlvaro Cerda, Adonai Aralim Amaral, Raquel de Oliveira, et al.
Pharmaceutics|May 28, 2022
Genetic Variant <i>ABCC1</i> rs45511401 Is Associated with Increased Response to Statins in Patients with Familial HypercholesterolemiaCarolina Dagli-Hernandez, Jéssica Bassani Borges, Elisangela da Silva Rodrigues Marçal, et al.
Pageof 6